Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1101 to 1150 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1101\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lysyl-trna synthetase (ec 6.1.1.6) (lysine--trna ligase) (lysrs). [source:swissprot;acc:q15046]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
220.291\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.584\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02857\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1102\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s27 (metallopan-stimulin 1) (mps-1). [source:swissprot;acc:p42677]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
229.442\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
235.974\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02847\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1103\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein s27-like protein; 40s ribosomal protein s27 isoform. [source:refseq;acc:nm\_015920]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
229.441\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
235.972\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02846\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1104\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hydroxyacid oxidase 1 (ec 1.1.3.15) (haox1) (glycolate oxidase) (gox). [source:swissprot;acc:q9ujm8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
231.922\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
238.486\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0283\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1105\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adrenodoxin, mitochondrial precursor (adrenal ferredoxin) (hepatoredoxin) (ferredoxin 1). [source:swissprot;acc:p10109]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
191.139\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
185.882\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02828\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1106\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pxr2b protein. [source:refseq;acc:nm\_016559]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.945\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.109\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02818\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1107\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine palmitoyltransferase 2 (ec 2.3.1.50) (long chain base biosynthesis protein 2) (lcb 2) (serine-palmitoyl-coa transferase 2) (spt 2). [source:swissprot;acc:o15270]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
204.603\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.324\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02796\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1108\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
interleukin enhancer-binding factor 1 (cellular transcription factor ilf-1). [source:swissprot;acc:q01167]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.006\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.119\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02775\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1109\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translationally controlled tumor protein (tctp) (p23) (histamine- releasing factor) (hrf). [source:swissprot;acc:p13693]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.098\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.209\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1110\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
arf gtpase-activating protein git2 (g protein-coupled receptor kinase- interactor 2). [source:swissprot;acc:q14161]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.782\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02769\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1111\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
apoptosis inhibitor fksg2. [source:swissprot;acc:q9hau6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.123\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02766\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1112\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocyte nuclear factor 4-gamma (hnf-4-gamma). [source:swissprot;acc:q14541]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
251.863\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
258.829\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1113\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
growth arrest and dna-damage-inducible protein gadd45 gamma (cytokine responsive protein cr6). [source:swissprot;acc:o95257]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1114\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
growth arrest and dna-damage-inducible protein gadd45 alpha (dna- damage inducible transcript 1) (ddit1). [source:swissprot;acc:p24522]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1115\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocyte nuclear factor 4-alpha (hnf-4-alpha) (transcription factor hnf-4) (transcription factor 14). [source:swissprot;acc:p41235]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1116\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
growth arrest and dna-damage-inducible protein gadd45 beta (negative growth-regulatory protein myd118) (myeloid differentiation primary response protein myd118). [source:swissprot;acc:o75293]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1117\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear rna export factor 5 (tap-like protein 1) (tapl-1). [source:swissprot;acc:q9h1b4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
168.989\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
164.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02754\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1118\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear rna export factor 3 (tap-like protein 3) (tapl-3). [source:swissprot;acc:q9h4d5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
168.995\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
164.467\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02753\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1119\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar proton translocating atpase 116 kda subunit a isoform 2 (v-atpase 116-kda isoform a2) (tj6). [source:swissprot;acc:q9y487]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
218.528\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
212.676\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02752\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1120\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atpase, h+ transporting, lysosomal v0 subunit a isoform 4; vacuolar proton pump 116 kda accessory subunit; vacuolar proton pump, subunit 2; h(+)-transporting two-sector atpase, noncatalytic accessory protein 1b; atpase, h+ transporting, lysosomal (vacuolar proton pump) non-catalytic accessory protein 1b; renal tubular acidosis; atpase, h+ transporting, lysosomal (vacuolar proton pump) non-catalytic accessory protein 2 (38kd). [source:refseq;acc:nm\_020632]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1121\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar proton translocating atpase 116 kda subunit a isoform 1 (clathrin-coated vesicle/synaptic vesicle proton pump 116 kda subunit) (vacuolar proton pump subunit 1) (vacuolar adenosine triphosphatase subunit ac116). [source:swissprot;acc:q93050]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.529\vspace{3pt}}&&\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1122\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar proton translocating atpase 116 kda subunit a isoform 3 (v- atpase 116-kda isoform a3) (osteoclastic proton pump 116 kda subunit) (oc-116 kda) (oc116) (t-cell immune regulator 1) (t cell immune response cdna7 protein) (tirc7). [source:swissprot;acc:q13488]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.527\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1.02751\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1123\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear rna export factor 1 (tip associating protein) (tip-associated protein) (mrna export factor tap). [source:swissprot;acc:q9ubu9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
169.031\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
164.507\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0275\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1124\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxiredoxin 5, mitochondrial precursor (prx-v) (peroxisomal antioxidant enzyme) (plp) (thioredoxin peroxidase pmp20) (antioxidant enzyme b166) (aoeb166) (tpx type vi) (liver tissue 2d-page spot 71b) (alu co-repressor 1) (sbbi10). [source:swissprot;acc:p30044]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
207.553\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.256\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02748\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1125\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj718p11.1.2 (novel class ii aminotransferase similar to serine palmotyltransferase (isoform 2)) (fragment). [source:sptrembl;acc:q9ugb5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
204.404\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.022\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1126\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atpase, h+ transporting, lysosomal 38kda, v0 subunit d isoform 2. [source:refseq;acc:nm\_152565]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.487\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.656\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02742\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1127\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolar protein nop5 (nucleolar protein 5) (nop58) (hspc120). [source:swissprot;acc:q9y2x3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
239.219\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
232.837\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02741\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1128\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein six1 (sine oculis homeobox homolog 1). [source:swissprot;acc:q15475]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.286\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.399\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02733\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1129\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein six2 (sine oculis homeobox homolog 2). [source:swissprot;acc:q9npc8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
221.285\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.401\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02732\vspace{3pt}}}\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1130\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proliferation-associated protein 2g4 (cell cycle protein p38-2g4 homolog) (hg4-1). [source:swissprot;acc:q9uq80]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
215.4\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1131\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit g 2 (ec 3.6.3.14) (v-atpase g subunit 2) (vacuolar proton pump g subunit 2) (v-atpase 13 kda subunit 2). [source:swissprot;acc:o95670]\vspace{3pt}}&\multirow{14}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
218.484\vspace{3pt}}}&\multirow{15}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
212.675\vspace{3pt}}}&\multirow{14}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02731\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1132\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
apoptosis inhibitor 5; fibroblast growth factor 2-interacting factor 2; api5-like 1. [source:refseq;acc:nm\_006595]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1133\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sec13-related protein. [source:swissprot;acc:p55735]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1134\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit g 3 (ec 3.6.3.14) (v-atpase g subunit 3) (vacuolar proton pump g subunit 3) (v-atpase 13 kda subunit 3). [source:swissprot;acc:q96lb4]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1135\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit b, brain isoform (ec 3.6.3.14) (v-atpase b2 subunit) (vacuolar proton pump b isoform 2) (endomembrane proton pump 58 kda subunit) (ho57). [source:swissprot;acc:p21281]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1136\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
yeast sec31p homolog. [source:refseq;acc:nm\_014933]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1137\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit g 1 (ec 3.6.3.14) (v-atpase g subunit 1) (vacuolar proton pump g subunit 1) (v-atpase 13 kda subunit 1) (vacuolar atp synthase subunit m16). [source:swissprot;acc:o75348]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1138\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit e (ec 3.6.3.14) (v-atpase e subunit) (vacuolar proton pump e subunit) (v-atpase 31 kda subunit) (p31). [source:swissprot;acc:p36543]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1139\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ganglioside-induced differentiation-associated protein 1-like 1. [source:refseq;acc:nm\_024034]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1140\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dead (asp-glu-ala-asp) box polypeptide 39 isoform 1; nuclear rna helicase, decd variant of dead box family. [source:refseq;acc:nm\_005804]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1141\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ganglioside-induced differentiation-associated protein 1. [source:refseq;acc:nm\_018972]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1142\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit d (ec 3.6.3.14) (v-atpase d subunit) (vacuolar proton pump d subunit) (v-atpase 28 kda accessory protein). [source:swissprot;acc:q9y5k8]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1143\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
secretory pathway component sec31b-1. [source:refseq;acc:nm\_015490]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1144\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit h (ec 3.6.3.14) (v-atpase h subunit) (vacuolar proton pump h subunit) (v-atpase 50/57 kda subunits) (vacuolar proton pump subunit sfd) (cgi-11). [source:swissprot;acc:q9ui12]\vspace{3pt}}&&&\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1145\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit f (ec 3.6.3.14) (v-atpase f subunit) (vacuolar proton pump f subunit) (v-atpase 14 kda subunit). [source:swissprot;acc:q16864]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.481\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0273\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1146\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit b, kidney isoform (ec 3.6.3.14) (v- atpase b1 subunit) (vacuolar proton pump b isoform 1) (endomembrane proton pump 58 kda subunit). [source:swissprot;acc:p15313]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.483\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.676\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1147\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal membrane protein pex14 (peroxin-14) (peroxisomal membrane anchor protein pex14) (pts1 receptor docking protein). [source:swissprot;acc:o75381]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
208.651\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.109\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02729\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1148\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin. [source:swissprot;acc:p02248]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
209.061\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.518\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02724\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1149\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bystin. [source:swissprot;acc:q13895]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
239.505\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
233.185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0271\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1150\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sorting nexin 1. [source:swissprot;acc:q13596]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
209.868\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.522\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02694\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/